Soralieva 200mg Tablet: Multi-Kinase Inhibition for Advanced Hepatic, Renal, and Thyroid Oncology Are you searching for a reliable Soralieva 200 mg tablet exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted multi-kinase inhibitors. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical oncology medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Soralieva 200mg? Universal SEO Page Title (Multi-City Targeted) Soralieva 200mg Tablet | Wholesale Sorafenib Exporter to London, Washington, Canberra, Johannesburg & Singapore—Ernest Oncology Soralieva 200mg Tablet: Multi-Kinase Inhibition for Advanced Hepatic, Renal, and Thyroid Oncology Are you searching for a reliable Soralieva 200 mg tablet exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted multi-kinase inhibitors. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical oncology medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Soralieva 200mg? Soralieva 200mg is an oral targeted therapy containing the active pharmaceutical ingredient Sorafenib. Manufactured by Allieva Pharma Pvt Ltd, this 200mg tablet is a potent multi-kinase inhibitor designed to treat various types of cancers by attacking both the cancer cells and the blood vessels that supply them. It represents a significant advancement in the non-surgical management of advanced solid tumors. 1. Therapeutic Indications Hepatocellular Carcinoma (HCC): Indicated for the treatment of patients with unresectable liver cancer. Advanced Renal Cell Carcinoma (RCC): Used for patients with advanced kidney cancer who have failed prior cytokine-based therapy or are unsuitable for it. Differentiated Thyroid Carcinoma (DTC): Specifically for locally advanced or metastatic, progressive, differentiated thyroid carcinoma that is refractory to radioactive iodine. 2. Mechanism of Action: The Dual-Action Approach Anti-Proliferative Activity: It inhibits the Raf/MEK/ERK signaling pathway. By blocking these intracellular kinases, it directly prevents the division and growth of cancer cells. Anti-Angiogenic Activity: It targets cell surface tyrosine kinases, including VEGFR-2, VEGFR-3, and PDGFR-beta. This “starves“ the tumor by inhibiting the development of new blood vessels (angiogenesis) required for tumor survival and expansion. 3. Administration and Dosage Management Standard Dosing: The typical recommended dose is 400mg (two 200mg tablets) taken twice daily. Administration: For optimal absorption, Soralieva should be taken either 1 hour before or 2 hours after a meal (on an empty stomach). Consistency: Tablets must be swallowed whole with a glass of water. Do not crush or chew the tablets. Clinical Side Effects & Safety Monitoring Hand-Foot Skin Reaction (HFSR): Redness, pain, or swelling on the palms and soles is common; early management with topical creams is advised. Hypertension (High Blood Pressure): Blood pressure usually increases within the first few weeks; regular monitoring is essential. Gastrointestinal Health: Potential for diarrhea, fatigue, and weight loss. Cardiovascular Safety: Patients should be monitored for signs of myocardial ischemia or infarction. Dermatological Safety: Patients should report any new skin lesions or significant rashes immediately. Why Source Soralieva 200mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva Pharma’s Soralieva with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex import/export regulations for the USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us